Program Leaders: Constantinos Koumenis, PhD and Amit Maity, MD, PhD
The Radiobiology and Imaging Program seeks to improve patient outcomes through the advanced understanding of how ionizing and non-ionizing radiation interacts with cancer and normal tissues. The Programmatic goals are to:
- Study molecular mechanisms of radiation response and identify targets to improve radiotherapy
- Elucidate mechanisms underlying use of Photodynamic Therapy (PDT) and translate to the clinic
- Develop methods for measuring and altering tumor oxygenation and metabolic status and understand the molecular events governing cell death by IR and physiological stresses
- Develop novel techniques to image the interaction between radiation, PDT and tissues
- Understand the biological effects of protons to inform their effective clinical use
The Program has moved towards new areas of inter-Programmatic emphasis including combined radiation and immunotherapy modalities and precision medicine, and it has expanded the incorporation of imaging modalities into basic and translational efforts. A major development has been the substantial expansion of both translational and clinical studies of proton therapy.
Radiobiology and Imaging Program Membership
Sunday Akintoye, DDS, MS
Abass Alavi, MD
Edgar Ben-Josef, MD
Abigail Berman, MD, MSCE
Stefan Both, PhD
Theresa Busch, PhD
Keith Cengel, MD, PhD
Christos Davatzikos, PhD
Jay Dorsey, MD, PhD
Sydney Evans, VMD, MS
Andrea Facciabene, PhD
Yi Fan, MD, PhD
Michael Farwell, MD
Peter Gabriel, MD, MSCE
Warren Gefter, MD
Eli Glatstein, MD
Jerry Glickson, PhD
Christine Hill-Kayser, MD
Gary Kao, MD, PhD
Joel Karp, PhD
Constantinos Koumenis, PhD
Lin Li, PhD
Alexander Lin, MD
Robert Lustig, MD
Robert Mach, PhD
Amit Maity, MD, PhD
David Mankoff, MD, PhD
John Plastaras, MD, PhD
Anitoliy Popov, PhD
Daniel Pryma, MD
Rahim Rizi, PhD
Mark Rosen, MD, PhD
Sunil Singhal, MD
Michael Soulen, MD
Andrew Tsourkas, PhD
Neha Vapiwala, MD
Sergei Vinogradov, PhD
Jeffrey Winkler, PhD
Timothy Zhu, PhD